3-Azetidinecarboxylic acid, 1-(3-bromo-2-pyridinyl)-, 100mg

(R)-3-Methylmorpholine hydrochloride, 95.0%, 1g

(S)-Methyl 6-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-aminohexanoate hydrochloride, 97%, 5g

2,6-Difluoroaniline>98.0%(GC)25g

Acetic acid, 2-methoxy-, (1S,2S)-2-[2-[[3-(1H-benzimidazol-2-yl)propyl]methylamino]ethyl]-6-fluoro-1,2,3,4-tetrahydro-1-(1-methylethyl)-2-naphthalenyl ester, hydrochloride (1:2), 97%, 25mg

5-Chlorothiophene-2-carboxylic acid, 98.0%, 1g

Ethyl 3-(2-chlorophenyl)propanoate, 95.0%, 5g

3-(3-methoxy-4-nitrophenyl)-9-methyl-3,9-diazaspiro[5.5]undecane, 95.0%, 100mg

6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-benzofuran, 95.0%, 250mg

Colonne HPLC NUCLEODUR® NH2 5 µm, 150 mm, 4,6 mm, 1 pièce(s)

2-Bromobenzoyl chloride, 98.0%, 100g

2-(N-ISOPROPYLMETHYLSULFONAMIDO)ACETIC ACID, 95.0%, 250mg

Sodium L-tartrate dibasic dihydrate, 99.0%, 250g